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Abstract
Effect of antibiotic use on the incidence of 
asthma and atopic dermatitis in infants
- For the 2011-13 births of Republic of Korea -
MoonGyu Lee
Department of Public Health
Graduate School of Public Health
Seoul National University
Background: Previous studies have shown that both asthma and atopic dermatitis are 
caused by allergic marching in the childhood, with their cooccurrence or with some pre-
existing relationship. Because of these relationship, the behavior of both diseases and 
their risk factors have been jointly investigated. Asthma and atopic dermatitis are from
the complex interplay various factors such as demographic factors, infectious disease 
related factors, medicinal use factors, dietary related factors, and atmospheric 
environmental factors are mixed and acting together. Among the various risk factors, the 
use of antibiotics has been studied to cause long-term changes in intestinal 
microorganisms such as decreased actinomycetes, increased bacteria, and decreased 
enzymes. It has also been studied to increase the incidence of allergic sensitization to 
allergies such as asthma and atopic dermatitis by inhibiting the proper growth of 
infantile immune system and inhibiting the development of immune tolerance because it 
causes an increase in the immature microbial growth. Nevertheless, due to the difficulty 
in diagnosing asthma and atopic dermatitis of less than 5 years old, there have been few 
studies about disease status and on the risk factors including antibiotic use.
Objective: The purpose of this study is to investigate the effect of antibiotics use in 
infants on the risk of asthma and atopic dermatitis with the current status of asthma and 
atopic dermatitis of newborns between 2011 and 2013 in Korea. 
Method: This study used claims data of the Health Insurance Review and Assessment 
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Service of newborns born in 2011, 2012, and 2013 in Korea. The registered analysis 
number of the data requested by the Health Insurance Review and Assessment Service is 
M2016082442, which is applied to the remote access system and granted access to data. 
The data to be used in this study were composed by combining the general information, 
healthcare information, diagnostic information and prescriptions information based on 
the patient identification code and the key code. The directed acyclic graph (DAG) was 
made through literature review, and was used to choose confounding variables. 
Frequency analyses were performed to examine the characteristics of the data, and the 
prevalences and incidence rates of asthma and atopic dermatitis were estimated.
Incidence was estimated by person-month. Kaplan-Meier survival curves were estimated
for subjects with the antibiotic use before the diseases, with the antibiotic use before the 
disease and the respiratory disease, and with the respiratory disease in the antibiotic use
and pyelonephritis. Finally, the cox proportional hazard model was used to estimate the 
hazard ratio for the use of antibiotics in the development of asthma and atopic dermatitis. 
This study also estimated the hazard ratio for the development of asthma and atopic 
dermatitis according to the type of antibiotics proposed by WHO.
Results: The prevalence of asthma was about 60% and its incidence rate was 0.0238 
per person-month who were less than one year old in 2011-2013, and the prevalence of 
atopic dermatitis was about 80% and incidence rate was 0.0845 per person-month. Both 
diseases were found to have higher prevalence and incidence rates for subjects using 
antibiotics before the diseases. DAG reveals that respiratory disease is a main 
confounder between asthma, atopic dermatitis and antibiotics, and the subjects were 
categorized into four different groups based on the antibiotics use and respiratory 
diseases. Kaplan-Meier survival curves show that both asthma and atopic dermatitis 
were associated with the highest risk in the group of antibiotic use and respiratory 
disease. The log-rank test also showed that there was a substantial difference in the 
survival functions between groups because the significance probability was less than 
0.0001. Finally, the hazard ratio of antibiotic use before asthma in the Cox proportional 
hazards model was estimated to be 1.556 (95% CI: 1.543 - 1.569) for the development 
of asthma, and hazard ratio of antibiotic use before atopic was estimated to be 1.369   
(95% CI: 1.360 - 1.378) for the occurrence of atopic dermatitis. The hazard ratio of 
antibiotic use for asthma among subjects with respiratory diseases was estimated to be 
1.518 (95% CI: 1.510 - 1.527) and the hazard ratio for atopic dermatitis was estimated to 
be 1.210 (95% CI: 1.205 - 1.215). Effects of different antibiotics were estimated with 
the Cox proportional hazards model, and hazard ratios of the beta-lactam antibacterials 
and penicillins for asthma was 1.682 (95% CI: 1.668-1.695), and those for atopic 
dermatitis was 1.408 (95% CI: 1.399 – 1.417).
Conclusion: In this study, the use of antibiotics before the onset of asthma and atopic 
dermatitis was found to be an important risk factor affecting the incidence of asthma and 
iii
atopic dermatitis. Especially, the effect of beta-lactam antibacterials, penicillins on the 
incidence of asthma and atopic dermatitis was found to be the largest among antibiotics, 
and thus we can conclude that careful prescription for those antibiotics may be 
necessary to minimize the risk of asthma and atopic dermatitis in infants.
Keywords : Asthma, Atopic dermatitis, Antibiotics, Cox 
proportional hazard model, Kaplan-Meier curve
Student Number : 2015-24013
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Ⅰ. Introduction
1. Background & Necessity
Asthma is one of the most common chronic diseases in the world. The 2014 ISAAC 
study reported that around 344 million people worldwide suffered from asthma as of 
2008-2010. This is higher than the 2000-2002 report, estimated at about 242 million 
people, indicating that the rate of asthma growth has increased faster than the rate of 
global population growth. The prevalence of global asthma in childhood is estimated to 
be about 14% in 2008-2010, and the prevalence of asthma in Korean children is 
estimated to be 8.7%. 
A recent epidemiological survey based on the ISAAC protocol shows the estimates of
the prevalence of allergic diseases in Korea in 2010. This study involved 4,000 children 
who are 6-7 years, and 13-14 years old in Korea. The prevalence of asthma was 
estimated to be approximately 10.3% (95% confidence interval [CI]: 9.2-11.4) in the 
former group and 8.3% (95% CI: 7.4-9.2) in the latter. The prevalence of eczema, a 
symptom of atopic dermatitis, was estimated to be 17.9% (95% CI 16.6-19.3) in 
children 6-7 years, and 11.2% (95% CI 10.1-12.3) in 13-14 years of age.
Research on the prevalence of asthma and atopic dermatitis in Korea using data from 
Korea National Health and Nutrition Examination Surveys (KNHNES) is also actively 
being conducted. Their estimates for the prevalence of adult asthma were 3.1% in 2011, 
2.8% in 2012, 3.0% in 2013 and 3.0% in 2014, showing no big difference.
However, the prevalence of asthma in elementary school students is estimated to be 
10.2% in 2010, a 2.5%p increase from 7.7% in 1995. The proportion of experienced 
patients in elementary school increased from 17% in 1995 to 18.7% in 2010. In adult 
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atopic dermatitis, the prevalence was 3.0% in 2011, 2.9% in 2012, 3.0% in 2013 and 3.0% 
in 2014. 
Korea is one of the countries with the highest antibiotic consumption per capita in the 
world. According to a 2004 study using the Insurance Claims Data of Korea National 
Health Insurance Service, 23.62 people per 1,000 people were taking antibiotics in 
Korea. It was found that males tend to use more antibiotics, and the dose of antibiotics 
was the highest in children under 7 years of age (47.13 per 1,000). In comparison, the 
US and EU (27 countries) antibiotics usage rates in 2004 were 24.92 and 19.04 per 
1,000 respectively. In particular, amount of antibiotics consumption is increasing in 
BRICS (Brazil, Russia, India, China, South Africa) in developing countries. They found 
that antibiotics with the highest use in children were beta-lactam antibacterials, 
penicillins, followed by cephalosporins and macrolides. People in the metropolitan areas 
tend to use more antibiotics than people in the small cities or rural areas.
Previously, there were efforts to clarify the link between the use of antibiotics and 
asthma & atopic dermatitis. Various studies investigated effects of antibiotics during 
infancy and childhood on the incidence of pediatric asthma and the effects of maternal 
antibiotics during pregnancy on the incidence of pediatric asthma and atopic dermatitis
to clarify the association between the use of antibiotics and the occurrence of asthma 
and atopic dermatitis. However, due to limitations caused by the complex interplay 
among multiple risk factors for asthma and atopic dermatitis with multiple risk factors 
and small sample size, some inconsistency of their results have been found among them.
Recent studies found associations between antibiotic use and asthma through a case-
sibling study design, and they showed that antibiotics during pregnancy can lead to the 
higher incidence of asthma in school-aged children.
Health insurance claims data records which medical services an insurer, such as a 
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hospital, a clinic, or a health center, provided to patients. Many health policy decision 
makers are creating policies that incorporate evidence from a variety of studies. In 
particular, real world data is used to make health policy decisions because it contains the 
patient's actual treatment records and can be used to assess long-term safety and 
effectiveness as well as economic efficiency. Due to the health insurance system in 
Korea, claims data have detailed medical data including diagnosis data and prescription 
drugs. The data also include information about the health services of all citizens. In this 
thesis, I focused on the medical claims data managed by Health Insurance Review & 
Assessment Service (HIRA) in Korea, which is dataset for the whole nation. This data 
includes most Koreans on births, and the details of medical use, drug use and disease 
code were included. Therefore, the general conclusion about associations between
asthma, atopic dermatitis and antibiotics in Koreans can be obtained.
2. Objectives
The aim of this study is to investigate the prevalence and incidence rate of asthma and 
atopic dermatitis and the status of antibiotic use in 2011-2013 using the claims data of 
HIRA in Korea. In addition, this study will investigate the effect of antibiotic use on the 
risk of asthma and atopic dermatitis. To do this, this study explored the complex risk 
factors associated with asthma and atopic dermatitis and analyzed the effects of 
antibiotic use on asthma by appropriately controlling and correcting risk factors. In 
particular, this study will estimate the effect by the different types of antibiotics. An 
appropriate statistical model will be presented to clarify the association between 
antibiotics and asthma & atopic dermatitis by correcting covariates and confounders. 
Especially, the main goal is to reduce the incidence of asthma and atopic dermatitis by 
presenting appropriate prescriptions of antibiotics when infant has respiratory disease. 
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To summarize, the results of the prevalence of asthma, the use of antibiotics, and the 
effects of antibiotics on the occurrence of asthma are used to suggest ways to reduce the 
risk of developing asthma and atopic dermatitis in children due to proper antibiotic 
prescription in infancy and childhood.
The detail purposes of this study are as follows:
1. To estimate the current state of asthma, and atopic dermatitis and antibiotic use in 
Korea’s 2011-2013 birth infant.
2. To assess the association between the use of antibiotics, and the incidence of 
asthma and atopic dermatitis in infancy.
3. To assess the association between the use of antibiotics, and the incidence of 
asthma and atopic dermatitis in infancy by different antibiotics type
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Ⅱ. Theoretical background
1. Asthma, atopic dermatitis and antibiotics
According to the 2007 report by National Heart, Lung, and Blood Institute (NHLBI) 
in the United States, asthma is defined as a chronic inflammatory disorder of the airways 
in which many cells and cellular element play a role. The cells and cellular refer to mast 
cells, eosinophils, neutrophils, T lymphocytes, macrophages and epithelial cells. 
Symptoms such as wheezing, difficulty breathing, and coughing (especially early 
morning or evening) can be caused by inflammation. The characteristics of asthma 
include bronchoconstriction, airway hyperresponsiveness, and Airway edema. The 
airflow obstruction of the airway caused by such inflammation can be said to induce the 
aforementioned symptoms.
Atopic dermatitis is defined as chronic disease that affects the skin according to the 
National Institutes of Health (NIH) for 2014. Atopy means that the allergic condition 
worsens, and dermatitis means swelling of the skin. Symptoms of atopic dermatitis 
include dry, cracking skin, rash, eczema and characteristics of atopic dermatitis are 
common in children and can be improved naturally when grown up (National Institute 
of Arthritis and Musculoskeletal and Skin Diseases, 2013). However, if they are 
constantly in a dry environment or are exposed to irritation, they may become affected. 
Particularly, children suffering from atopic dermatitis disease are known to be more 
likely to suffer from fever and asthma due to the allergy march. An allergy march is the 
concept that atopic dermatitis occurs in 1 to 3 years after birth, and the occurrence of 
asthma is likely to continue thereafter.
Antibiotics are substances that inhibit the growth microbiome and remove them to 
make antimicrobial action. Antibiotics were found in 1928 when Alexander Fleming did 
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not cultivate bacteria around the fungus in a fungal incubator during a staphylococcal 
culture experiment (Fleming, 1929). Fleming studied the substance contained in the 
fungus and that was named penicillin, which opened the era of antibiotics opening the 
era of antibiotics (Song, 2012). Antibiotics are divided into tetracycline, beta-lactam. 
Beta-lactam is divided into penicillin, 1-4th generation cephalosporin and so on. In this 
study, the types of antibiotics were classified into 16 categories according to world 
health organization (WHO) guidelines. The classified antibiotics were paired with the 
International Classification of Diseases, 10th revision (ICD-10) codes in the claims data 
of HIRA.
2. Risk factors of asthma and atopic dermatitis
The incidence of asthma and atopic dermatitis is known to be affected by a 
combination of various and complex risk factors such as demographic factors, infectious 
disease, medication, dietary factors, and atmospheric environment (Beasley, 2015). In 
demographic factors, age, sex, family history and my other factors are known. Infectious 
diseases are respiratory infections caused by viruses. Examples of medication factors are 
paracetamol, which is a component of antipyretic drugs, and antibiotics, which are 
antimicrobial (Beasley, 2015). Dietary factors such as vitamins, magnesium, and 
nutrients are known to be ingested, and the atmospheric environment factors include 
parental smoking, air pollution are known to be factors of asthma and atopic dermatitis
(Beasley, 2015).
The effect of sex on asthma and atopic dermatitis incidence may be related to age. 
The prevalence of asthma and atopic dermatitis is high in men before age 13, but after 
that it is known that the prevalence of asthma in women is higher (Melgert, 2007). The 
reason that age-specific gender differences are the main causes of asthma is not only 
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sociological and environmental differences but also biological differences. The 
biological difference between male and female refers to the change in hormones after 
the secondary sex characteristics. Estrogen, a female hormone, is secreted by women in 
the secondary sex, estrogen has an alpha receptor gene (ESR1). It has been studied that 
the alpha receptor gene (ESR1) is known to be reactive with bronchial tubes, which can 
increase the risk of asthma incidence (Dijkstra, 2006). 
Family history of asthma and atopic dermatitis is also a major risk factor for pediatric 
asthma (Guerra, 2008). The genetic impact of asthma does not clearly follow 
Mendelian’s laws. The reason for this is that it is difficult to unambiguously identify at 
the genetic level, as several genes affect asthma, methodological limitations and chronic 
factors.
3. The association of asthma and atopic dermatitis with antibiotics
Antibiotics are characterized by indiscriminate suppression of microbiomes that have 
positive effects as well as negative effects of antibiotic users. These features break the 
balance in intestinal microorganisms, which cause long-term changes in intestinal 
microbial composition, such as increasing actinomycetes, enzymes and decreasing 
bacteria (Blaser, 2011). These changes cause T cells to destroy insulin secreted from the 
pancreatic beta cells. Beta cells play a role in killing the causative bacteria of complex 
diseases. It has studied that the destruction affects the development of comorbid diseases 
such as asthma, atopic diseases, autoimmune diseases such as type 1 diabetes, familial 
Mediterranean fever and colitis. 
Previous studies (Strachan, 1989) have suggested a "hygiene hypothesis" of asthma 
incidence. Hygiene hypothesis is that factors such as individual hygiene status, birth 
order, and antibiotic use increase the prevalence of diseases such as atopic dermatitis 
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and asthma in western cultures. Recent some studies (Noverr, 2005) suggest that the 
hypothesis should be modified to include the role of gastrointestinal microorganisms. 
This is called a microflora hypothesis. One hypothesis states that diet and the use of 
antibiotics resulted in a decrease in microbiome and that changes in intestinal microbes 
resulted in an unmatured microbial growth (Noverr, 2005). Immature microbial growths 
increase the incidence of allergic sensitization by interfering with the proper growth of 
the immune system and by inhibiting the development of general immune tolerance.
In the study (Ortqvist, 2014), codes of antibiotics were separated by the classification 
method of Anatomical Therapeutic Chemical (ATC) into three broad categories, A, B 
and C. A contains all type of antibiotics, B which was known to be the highest hazard 
ratio is an antibiotic group used to treat respiratory infections such as penicillin and C is 
a group of antibiotics used in the treatment of urinary or skin, all of which three groups 
significantly increased the risk of asthma incidence. 
4. Directed acyclic graphs
As mentioned above, asthma and atopic dermatitis have complex risk factors. In 
adults, asthma can be diagnosed more clearly through diagnostic methods such as 
pulmonary function test, whereas pediatric asthma is difficult to perform pulmonary 
function tests. This makes diagnosis of childhood asthma less than 5 years old difficult.
Therefore, it is more desirable to estimate the disease by using operational definition 
rather than using the result of diagnosis in childhood asthma. This operational definition 
should be used to estimate risk factors through appropriate modeling of the major risk 
factors for asthma. Appropriate modeling of risk factors should precede proper search of 
causal graphs.
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A graph with causal directional information among causal graphs for analysis of 
factors is called a directional graph. Among them, graphs with no circulating arrows are 
called directed acyclic graphs (DAGs), a concept used in computer science, probability
theory, statistics, and so on. DAGs are often used in epidemiology because it allows 
causal reasoning for each factor by decomposing information about relations into 
probability distribution using conditional independence and joint probability distribution. 
In epidemiological studies, the precedence of DAGs can identify component of bias and 
selection of covariates or confounder for statistical correction and can help interpretation 
of causal inference (Vanderweele, 2011). Particularly, the analysis of causal direction 
can be made more precisely by analyzing covariates, confounders, and colliders.
Developing DAGs for research is difficult and can be bullish. Nevertheless, DAGs 
should be clarified through appropriate literature review and advice from clinical 
specialists. Therefore, the selection of the variables mentioned above and the 





This study used the claims data of HIRA from Korean children born in 2011-2013 in 
order to investigate the effects of antibiotics used in infancy on the incidence of asthma 
and atopic dermatitis. The registered analysis number of the data requested by HIRA is 
M2016082442, which is applied to the remote access system and granted access to data 
on the demographic information, the medical care and prescription of the newborn child 
in 2011-2013. Afterwards, analyses were carried out after eliminating the personally 
identifiable information from the result of remote analysis.
In the claims data of HIRA, Table 20 provides its general information, Table 40 
includes diagnostic information, and specific information on healthcare services 
provided, outpatient prescriptions and birth registration data can be obtained from Table 
30 and 53. Thus demographic factors are extracted from the data in Table 20 and the 
data combining the birth registration data with the patient ID. Then, the data of the 
individual's disease history (main disease and sub disease) and individual drug use 
history are extracted from Table 40, Table 30, and Table 53 by matching the billing 
statement identification code (key ID). Finally, they were merged by patients' ID. By 
merging in the same order as above, it is possible to identify outliers or missing values 
at the beginning of the merging phase and reduce the resources used for the analysis.
The outliers were defined as foreigners or those born with diseases corresponding to 
exclusion criteria whose information can be found in Table 2. The missing values were 
defined as the absence of information about the year of birth and month, or the absence 
of socioeconomic status (SES). In addition, errors of measurement in defining asthma 
disease could be reduced by combining disease code and drug code rather than only 
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using the disease code. The pipeline for the dataset configuration is shown in the 
following Figure 1.
Figure 1 The pipeline for the dataset configuration
The selection criteria of variables can be confirmed in Figure 2. The DAG was 
developed with following studies around antibiotics which are main exposure, asthma 
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and atopic dermatitis which are main outcome, and respiratory diseases which are 
confounder. The use of antibiotics is known to break down the balance of the 
microbiome and cause asthma and atopic dermatitis (Sekirov, 2010). Respiratory 
infections are treated with antibiotics and cause asthma and atopic deramtitis if they are 
caused by respiratory infections (Beasley, 2015). In childhood, asthma, atopic dermatitis 
and pyelonephritis have a high prevalence in boys (Melgert, 2007; Raszka, 2005). 
Because the incidence of pyelonephritis causes high temperature, prescription of 
paracetamol is made, and that may cause asthma and atopic dermatitis (Farquhar, 2009). 
In areas where birth area is urbanized, air pollution is severe, causing respiratory 
diseases, asthma and atopic dermatitis (Robinson, 2011). In the winter of the year, there 
are fewer outdoor exposures to vitamin D deficiency, and the nutritional status and 
stress of the mother cause asthma (Hollams, 2011).
Diagnostic and drug prescription codes for the operational definition of asthma and 
atopic dermatitis, which are outcomes of this study, were extracted from the disease 
history and drug use history stage. The main exposure of antibiotic use was extracted 
from the drug use history stage, and the main confounder respiratory disease was 
extracted from the disease history. In order to control covariates affecting asthma and 
dermatitis, this study extracted sex, birth season, residential area, and health insurance 
status at the demographic factor stage.
The FEV test in infancy was not provided in the claims data of HIRA and subjects 
were considered as asthma patients if they satisfy the following three requirements:
1. Subjects should be diagnosed three times or more within a year and intervals of any 
two consecutive diagnoses should be larger than or equal to one month.
2. Subjects should be prescribed three times or more asthma medications within a 
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year, and intervals of any two consecutive diagnoses should be larger than or equal to 
one month.
3. Dates for asthmatic diagnoses and medications should be same.
Diagnosis of asthma in the first requirement of operational definition can be obtained 
by a standard ATC code J45, J46, J21, and R062. Medications in the second requirement 
of operational definition can be obtained by a wide medication criteria which include 
about 360 different asthma-related medications. As a third requirement, we considered 
subjects with one-month interval or more between any two consecutive diagnoses and 
medications in order to detect chronic asthma. Furthermore, there are some possibility 
that the asthma diagnose code can be used to treat, and thus unless three detections 
occur within one year, we assume that asthma diagnoses were attributable to other 
diseases. The atopic dermatitis can be operationally defined by the diagnosis code L20 
which is much less complicated than the operational definition of asthma. 
The WHO-designated ATC code is commonly used to study disease occurrence by 
antibiotics type. However, claims data of HIRA is classified by ingredient code, not 
ATC code. The ingredient code is 9 digits and contains information on the active 
ingredient, drug strength & unit, route of administration, and dosage form (Jang, 2011).
So, approximately 2,000 antibiotics were converted from ingredient codes to ATC codes
according to WHO guidelines (WHO Collaborating Centre for Drug Statistics Methodology, 
2016).
This study was conducted to investigate the effect of antibiotics on asthma and atopic 
dermatitis. Only the antibiotics taken prior to the date of asthma and atopic dermatitis as 
defined above were extracted. Sex is composed of two levels, male and female. In the 
case of the birth season, births were classified by quarter. The first quarter is winter, the 
- 14 -
second quarter is spring, the third quarter is summer, and the fourth quarter is autumn. In 
the case of the residential area, it was assumed that the first medical service of the 
newborn was provided because there was no data corresponding to the residential area. 
For the analysis, it was necessary to classify the residential area and it was divided into 
Seoul, metropolitan, Medium sized city, and small town to reflect the characteristics of 
Korea. Seoul is the capital of Korea, and metropolitan was classified as metropolitan 
cities or cities with a population of over 900,000. Medium sized cities are more than 
100,000 and less than 900,000, and small towns were classified as less than 100,000. 
Estimates of the number of population by municipal or district refer to the data on the 
website of the Statistics Korea. In order to estimate the SES, this study used the 
variables of health insurance subscribers or medical care receivers. This is because 
people who had difficulties in living were subscribed to medical benefits rather than 
health insurance, so SES could be estimated using these variables.
In addition, antibiotics were classified into 17 categories by using the taxonomy 
suggested in the WTO guidelines to analyze the effects of antibiotics on atopic 
dermatitis and asthma. The classification of antibiotics is shown in the following table.
ATC code Antibiotic types
J01A Tetracyclines
J01B Amphenicols
J01C Beta-Lactam antibacterials, Penicillins
J01D Other Beta-Lactam antibacterials
J01DB First-generation Cephalosporins
J01DC Second-generation Cephalosporins 
J01DD Third-generation Cephalosporins 




J01DI Other Cephalosporins and Penems
J01E Sulfonamides and Trimethoprim
J01F Macrolides, Lincosamides and Streptogramins
J01G Aminoglycoside antibacterials
J01M Quinolone antibacterials
J01R Combinations of antibacterials
J01X Other antibacterials
Table 1 Types of antibiotics according to ATC code
As mentioned in the theoretical background, in epidemiological studies, it is 
necessary to clarify DAG prior to the analysis of the research through appropriate 
literature review and consultation with clinical experts. Especially, in case of atopic 
dermatitis and asthma, the factors of disease are complex, so it is important to clarify the 
DAGs and control the factors one by one. 
The DAG for antibiotics of asthma and atopic dermatitis is as follows:
Figure 2 DAG of asthma and atopic dermatitis.
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As shown in the DAG, the major confounder of antibiotics and pediatric asthma and 
atopic dermatitis is respiratory disease. The prevalence of pyelonephritis, asthma and 
atopic dermatitis are high in males. The higher the air pollution level in the birth area, 
the higher the risk of asthma and atopic dermatitis incidence. The lower the exposure
dose of sunlight in the winter and the worse the mother's psychological state and 
nutrition, the higher the prevalence of asthma and dermatitis in children.
In addition to the risk factors presented in the graph above, other factors such as low 
birth weight, musculoskeletal disorders, and congenital heart disease are also known to 
be risk factors for asthma and dermatitis incidence. However, the final goal of this study 
is to provide an appropriate prescription of antibiotics for infants with respiratory 
disease. It is not appropriate to control and analyze other diseases, and the prevalence of 
the diseases is also low. So this study set up exclusion criteria.
The list of exclusion criteria and the ICD-10 code are as follows:
Disease ICD-10 code
Low birth weight infant P070, P071, P0711, P0712, P0713, P0714
Premature P072
Intrauterine growth retardation P059
Obstructive bronchitis J44
Congenital heart disease Q2
Congenital malformations of the respiratory 
system
Q3
Respiratory and cardiovascular disorders 
Specific to the perinatal period
P220
Muscular skeletal disease G7, Q7
Inborn error of metabolism Q8, Q9
Immune deficiency diseases D8
Table 2 list of ICD-10 code for exclusion criteria
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2. Hypotheses
The hypotheses for achieving the above objectives in this study are as follows:
1. The use of antibiotics in infancy may affect the incidence of asthma.
2. The use of antibiotics in infancy may affect the incidence of atopic dermatitis.
3. The use of antibiotics by type of infant may affect the incidence of asthma.
4. The use of antibiotics by type of infant may affect the incidence of atopic dermatitis.
3. Statistical methods
Frequency analysis, prevalence and incidence estimation, and survival analysis were 
conducted. Frequency analysis was carried out to estimate the distributions of basic 
demographic variables such as gender and birth area in 2011-2013 and to confirm the 
use of antibiotics in Korean children. In the case of prevalence, the percentage of 
patients with asthma and atopic dermatitis was calculated based on the period within one 
year of birth. Since subjects available for the birth claims data of HIRA in Korea are 
very large, the standard errors are very small and CI estimates are not included. The 
incidence rate was calculated on the basis of person-month rather than person-year, and
their 95% CIs were estimated by assuming Poisson distribution for disease occurrence. 
Time to asthma and atopic dermatitis onsets was analyzed with the crude Kapan-Meier 
curve analysis, which is a method of estimating the survival function by major groups 
until the asthma and atopic dermatitis incidence respectively, and the Cox proportional 
hazards model, which estimates the effect of only antibiotic use on diseases by adjusting
the effects of confounders in DAGs.
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The Kaplan-Meier analysis estimates subjects’ conditional probability at each time 
point that asthma and atopic dermatitis occur, and they were used to calculate the 
survival rate by multiplying the estimated probabilities. For the Kaplan-Meier analysis,
occurrence time of the event should be clarified and the starting point of the survival 
time is defined by the time of birth. Events are defined by the occurrence of asthma and 
atopic dermatitis. Specifically, for atopic dermatitis, the first diagnosis of L20 diagnosis 
among main diagnosis and sub-diagnosis is defined as the time point of occurrence of 
atopic dermatitis by operational definition. For asthma, the date of the first prescription 
and diagnosis was defined as the point in time of asthma, during the three prescriptions 
and diagnoses at intervals of one month or more in the operational definition. 
If times to onset of asthma or atopic dermatitis are    ,   , ⋯ ,    , the numbers of events
at time points are   ,   , ⋯ ,   , and the number of people who can develop disease at 
time points are   ,   , ⋯ ,   , the hazard rate at time point t  can be defined as h(  ) =
  /   . The survival function S(  ) can be estimated to be S(  ) =  (    ) ×
 1 − ℎ(  ) , S(  ) = 1 for each time point. The Kaplan-Meier Curve is a graph of the 
survival function S( ) at each point in time. The survival function S( ) is as follows:
S( ) = P[T >  ] = 1 − P[T ≤  ] = 1 − F( )
T is the random variable of the disease occurrence time and F( ) is the cumulative 
probability distribution.
Kaplan-Meier analyses were conducted for three different goals. First, the crude 
Kaplan-Meier curves for the disease-free antibiotic-treated subjects, the antibiotic-
untreated subjects, and all subjects were separately generated, and the differences
among three groups was tested. Second, subjects are separated into four groups 
depending on the respiratory disease status before the onset of the diseases because 
- 19 -
respiratory diseases are often known as confounder of asthma and atopic dermatitis and 
the effect of respiratory diseases should be adjusted. Third, subjects were divided into 
two groups according to the presence or absence of respiratory disease in patients who 
had pneumonia prior to the disease and took antibiotics. 
Differences of survival functions between different groups were tested by log-rank 
test. The log-rank test is a non-parametric method and can test whether events occurs in 
proportion to the number of subjects in both groups. That is. In the Kaplan-Meier 
analysis, it is often used to test the differences of survival function among groups. 
The Cox proportional hazards model was used to estimate the effect of antibiotics on 
the incidence of asthma and atopic dermatitis when effects of confounders and 
covariates are adjusted. The Cox proportional hazard model (Cox, 1972) can be modeled 
by
h( ;   ) = h ( ) × exp(      +⋯+      )
Here h( ) is the baseline risk function at each time point in time, and   ,⋯ ,   
indicates covariates. The logistic model uses the disease status as response variable but 
the Cox proportional hazard model can estimate the effect of covariates on time to onset.
Therefore, Cox proportional hazard model is useful if disease status is unclear. Disease 
status is often unclear for controls because they have a chance to be affected. In the case 
of the claims data used in this study, the study period was set up until the first year after 
birth or when the follow-up was not made. For this reason, this data can be considered to 
be right-censored. So, the effects of antibiotics were estimated using the Cox proportion 
hazard model. The use of antibiotics was limited to pre-asthma use to estimate the effect 
of antibiotics taken prior to asthma. The use of antibiotics was limited to pre-asthma use 
to estimate the effect of antibiotics taken prior to asthma.
- 20 -
Ⅳ. Results
1. Characteristics of study population
Subjects who were born in Korea in 2011, 2012 and 2013 were used for analyses. 
There are 1440,836 subjects available in the claims data of HIRA in Korea, and some 
subjects who satisfy the following conditions were excluded. First, the foreigner or 
subjects with missing information about date of birth were excluded. Second, subjects 
whose SES are unknown are excluded. Last, subjects who satisfies the exclusion criteria
are removed. See the Table 2 for exclusion criteria. Figure 3 shows the summary for 
subject filtering described so far.
Figure 3 Procedure of data preparation
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Before investigating the effect of antibiotics on the incidence of asthma and atopic 
dermatitis, the use of antibiotics by type of antibiotics was summarized. The 17 
antibiotics mentioned in the method were categorized based on the types of antibiotics 
used. The use of antibiotics by the type of antibiotics in the claims data was confirmed 
in healthcare information (table 30) and prescriptions information (Table 53). When 
studying drug exposure research, it is known that it is necessary to utilize information
about healthcare and prescriptions to study more accurate drug use status.
Beta-Lactam antibacterials, penicillins was the most popularly used, and it was
followed by third-generation cephalosporins and macrolides, lincosamides and 
streptogramins among infants born between 2011 and 2013 according to the claims data 
of HIRA. The use of antibiotics by type is shown in Table 3.







J01A Tetracyclines 209 168 






















J01DF Monobactams 211 0 
J01DH Carbapenems 21,067 0 
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J01DI








Macrolides, Lincosamides and 
Streptogramins
1,094,479 12,370,868 
J01G Aminoglycoside antibacterials 733,576 319 
J01M Quinolone antibacterials 3,789 2,773 
J01R Combinations of antibacterials 6 7,659 
J01X Other antibacterials 39,713 8,199 
Table 3 The number of use by type of antibiotics
In the claims data of HIRA in Korean children born in 2011-2013, variables were 
collected for the risk factors in DAG. The risk factors identified in the claims data were 
sex, birth date, SES, birth area, diseases and medications. In our data 51% of subjects 
are males and 49% of them are females, and it is almost identical to gender ratio in 
Korea. Medium sized cities were the most common birth places (40.25%) followed by 
Metropolitan (37.21%). The birth quarter is mostly distributed evenly at 25%, but there 
is a slight imbalance between the first quarter (31.87%) and the fourth quarter (18.79%) 
in 2011. SES has been confirmed by the presence of Health insurance, and most of the 
subjects can be confirmed to be in Health insurance (99.35%). The medical care receiver 
case is used as an indicator of the poor. The major diseases, including asthma and atopic 
dermatitis, were identified by frequency and prevalence by year in operational 
definitions mentioned in the research method. The prevalence of asthma and respiratory 
diseases is similar to 60%, and atopic dermatitis is about 80% and pyelonephritis is 
about 2%. The frequency and percentage of the above-mentioned variables by year are 
shown in Table 4.
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Newborn in 2011 Newborn in 2012 Newborn in 2013 Total
n (%) n (%) n (%) n (%)
Demographics
Sex
Male 212,021 (51.23) 219,095 (50.90) 187,705 (50.82) 618,821 (50.99)
Female 201,824 (48.77) 211,359 (49.10) 181,631 (49.18) 594,814 (49.01)
Birth area
Seoul (Capital) 75,480 (18.24) 79,918 (18.57) 67,943 (18.40) 223,341 (18.40)
Metropolitans 150,742 (36.42) 161,661 (37.56) 139,144 (37.67) 451,547 (37.21)
Medium sized 
cities
169,326 (40.92) 171,594 (39.86) 147,508 (39.94) 488,431 (40.25)
Small town 18,294 (4.42) 17,281 (4.01) 14,741 (3.99) 50,316 (4.15)
Birth quarter
1st 131,886 (31.87) 101,182 (23.51) 88,429 (23.94) 321,497 (26.49)
2nd 106,979 (25.85) 102,449 (23.80) 86,868 (23.52) 296,296 (24.41)
3rd 97,216 (23.49) 117,402 (27.27) 95,048 (25.73) 309,666 (25.52)
4th 77,764 (18.79) 109,421 (25.42) 98,991 (26.80) 286,176 (23.58)
SocioEconomic Status
Health insurance 411,120 (99.34) 427,709 (99.36) 366,872 (99.33) 1,205,701 (99.35)
Medical care 2,725 (0.66) 2,745 (0.64) 2,464 (0.67) 7,934 (0.65)
Major disease
Asthma
Yes 246,323 (59.52) 266,156 (61.83) 224,746 (60.85) 737,225 (60.75)
No 167,522 (40.48) 164,298 (38.17) 144,590 (39.15) 476,410 (39.25)
Atopic dermatitis
Yes 329,386 (79.59) 349,223 (28.77) 297,838 (80.64) 976,447 (80.46)
No 84,459 (20.41) 81,231 (6.69) 71,498 (19.36) 237,188 (19.54)
Respiratory disease
Yes 294,572 (71.18) 251,074 (58.33) 212,256 (57.47) 757,902 (62.45)
No 119,273 (28.82) 179,380 (41.67) 157,080 (42.52) 455,733 (37.55)
Pyelonephritis
Yes 6,606 (1.60) 7,581 (1.76) 6,717 (1.82) 20,904 (1.72)
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No 407,239 (98.40) 422,873 (98.24) 362,619 (98.18) 1,192,731 (98.28)
Drugs under 1 year
Antibiotics
Yes 356,899 (86.24) 369,496 (85.84) 315,637 (85.46) 1,042,032 (85.86)
No 56,946 (13.76) 60,958 (14.16) 53,699 (14.54) 171,603 (14.14)
Paracetamol
Yes 299,541 (72.38) 325,758 (75.68) 279,605 (75.70) 904,904 (74.56)
No 114,304 (27.62) 104,696 (24.32) 89,731 (24.30) 308,731 (25.44)
Table 4 Characteristics of newborn between 2011 and 2013 in Korea by the claims data of 
HIRA
2. Prevalence and Incidence rate of asthma and atopic dermatitis
Prevalence and incidence of asthma and atopic dermatitis were estimated in order to 
examine the overall status of asthma and atopic dermatitis in the period from 2011 to 
2013. The prevalence was calculated by setting the period to be less than 1-year-old
between 2011 and 2013. The prevalence of asthma in all subjects by year was about 
60%, and the prevalence of asthma was higher in the group taking antibiotics before the 
onset of asthma than in the group not taking antibiotics. The prevalence of atopic 
dermatitis in all subjects was about 80%, which was higher than the prevalence of 
asthma. Similar to the prevalence of asthma, prevalence of atopic dermatitis is high in 
the group taking antibiotics before atopic dermatitis than in those not taking antibiotics.
Because the data on birth date were composed of quarters, the incidence of asthma 
and atopic dermatitis was determined by setting the person-month. The overall incidence 
of asthma was estimated to be 0.0238 (CI: 0.0238 to 0.0239), while the overall incidence 
of atopic dermatitis was estimated to be 0.0845 (CI: 0.0843 to 0.0847) higher than that 
of asthma. The prevalence of asthma and atopic dermatitis, as well as prevalence, was 
higher in the group taking antibiotics than in those not taking antibiotics. More 
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information on prevalence and incidence rate can be found from Table 5 and Table 6.
They show that antibiotic use is a risk factor for the development of asthma and atopic 
dermatitis. However, this does not consider respiratory diseases, which are important 
confounders of asthma and atopic dermatitis. Therefore, we analyzed the effects of 




Total 59.52% 61.83% 60.85%





Total 79.59% 81.13% 80.64%
Non-Antibiotics 10.27% 10.36% 10.50%
Antibiotics before 
incidence of atopic 
dermatitis
69.32% 70.77% 70.14%
Table 5 Prevalence of asthma and atopic dermatitis in infants under 1 year between 2011 
and 2013 by antibiotics
The number of event Incidence rate 95% CI
Asthma
Total 737,225 0.0238 0.0238 0.0239
Non-Antibiotics 83,021 0.0170 0.0169 0.0171
Antibiotics before 
incidence of asthma
654,204 0.0251 0.0250 0.0252
Atopic dermatitis
Total 976,447 0.0845 0.0843 0.0847
Non-Antibiotics 125,868 0.0591 0.0588 0.0594
Antibiotics before 
incidence of atopic 
dermatitis
850,579 0.0903 0.0901 0.0905
Table 6 Incidence rate of asthma and atopic dermatitis by antibiotics
- 26 -
3. Kaplan-Meier curve of asthma and atopic dermatitis by antibiotics, 
respiratory disease and pyelonephritis
As mentioned in the method, the Kaplan-Meier curves were generated for three 
purposes about asthma and atopic dermatitis. 
The first Kaplan-Meier curves among the three groups which consist of total, 
antibiotics use before the onset of asthma and non-use antibiotics. Both asthma and 
atopic dermatitis were found to occur more rapidly and frequently in subjects who use
antibiotics before onset of asthma than in those who did not use antibiotics according to
Figure 4. ‘a’ is the Kaplan-Meier curve of asthma and ‘b’ is the Kaplan-Meier curve of 
atopic dermatitis. The log-rank test was significant for both 'a' and 'b'. This is also the 
same in Figure 5 and Figure 6.
Figure 4 Kaplan-Meier curve of asthma and atopic dermatitis according to antibiotics use
respiratory disease is known as a confounder of asthma and atopic dermatitis and
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Kaplan-Meier curve analysis was provided in Figure 5 for four groups according to use 
of antibiotics and respiratory diseases. In the case of asthma, asthma occurred most 
frequently in subjects who had antibiotic use and respiratory diseases before the onset of 
asthma. This tendency was similar in 'b', atopic dermatitis. The incidence of atopic 
dermatitis was the highest in subjects who had antibiotics prior to disease and developed 
respiratory diseases. In both Kaplan-Meier curves, log-rank tests were significant.
Figure 5 Kaplan-Meier curve of asthma and atopic dermatitis grouped by antibiotics use 
and respiratory disease
Figure 6 depicted Kaplan-Meier curves of asthma and atopic dermatitis in groups of 
patients who developed pyelonephritis and who were taking antibiotics before each 
disease. Although pyelonephritis is not a direct risk factor for asthma, it is one of the 
representative diseases that use antibiotics in childhood. Therefore, the subjects who had 
pyelonephritis and used antibiotics were divided into groups according to respiratory 
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disease criteria. Both asthma and atopic dermatitis were found to be highly associated 
with respiratory diseases in those subjects.
Figure 6 Kaplan-Meier curve of asthma and atopic dermatitis grouped by respiratory 
disease in Pyelonephritis and antibiotics
4. Cox proportional hazard model of asthma and atopic dermatitis
To assess the status of asthma and atopic dermatitis in 2011-2013, the prevalences
and incidence rates were estimated, and the Kaplan-Meier curves were generated to 
compare the risks of asthma and atopic dermatitis according to antibiotic use before 
onset of diseases and respiratory diseases. As can be seen from DAGs, asthma is 
affected not only by antibiotics and respiratory diseases, but also by other risk factors. 
Therefore, effects of sex, birth time, and birth area affecting asthma and atopic 
dermatitis in DAGs need to be adjusted and the Cox proportional hazard models are 
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applied.
For Cox proportional hazard model, the use of antibiotics was set as the main 
exposure and fitted to the Cox proportional hazards model (Table 7). The hazard ratios 
according to the use of antibiotics before the disease were found to be 1.556 and 1.369
for asthma and atopic dermatitis, respectively. This means that taking antibiotics before 
the onset of the illness increases the risk of disease. Men also had higher risk of 
developing asthma and atopic dermatitis (hazard ratio 1.139, 1.107), respiratory disease 
before the onset of the disease, and higher risk of asthma and atopic dermatitis (hazard 
ratio 1.518 1.205). For birth area, the hazard ratio was higher in metropolitan compared 
to small town, but the hazard ratio in Seoul, the capital city of Korea, is low. For the 
birth quarter, the hazard ratio of the 4th quarter (reference) is higher than the others. The 
hazard ratio of paracetamol before the onset of the asthma and atopic dermatitis was 
0.541 and 0.681, respectively.
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Asthma Atopic dermatitis
HR 95%CI P-value HR 95%CI P-value
Antibiotics before each disease
Yes 1.556 1.543 1.569 <.0.0001 1.369 1.360 1.378 <.0.0001
No  (Reference)
Sex
Male 1.139 1.134 1.145 <.0.0001 1.107 1.103 1.112 <.0.0001
Female  (Reference)
Respiratory disease before each disease
Yes 1.518 1.510 1.527 <.0.0001 1.210 1.205 1.215 <.0.0001
No (Reference)
Birth area
Seoul 0.954 0.942 0.967 <.0.0001 1.016 1.005 1.028 0.0052 
Metropolitans 1.065 1.052 1.078 <.0.0001 1.073 1.062 1.085 <.0.0001
Medium sized cities 1.125 1.111 1.139 <.0.0001 1.109 1.097 1.121 <.0.0001
Small town  
(reference)
Birth quarter
1st 0.969 0.962 0.975 <.0.0001 0.870 0.865 0.875 <.0.0001
2nd 0.984 0.977 0.991 <.0.0001 0.910 0.905 0.915 <.0.0001
3rd 1.002 0.995 1.009 0.5666 0.960 0.954 0.965 <.0.0001
4th (Reference)
Paracetamol before each disease
Yes 0.541 0.538 0.544 <.0.0001 0.681 0.677 0.684 <.0.0001
No (reference)
Table 7 Cox proportional hazard model of the risk factors of asthma and atopic dermatitis
Second, the effects of types of antibiotics were tested with the Cox proportional 
hazards model (Table 8). Effects of each antibiotic types were estimated with subjects 
who took the antibiotic before the onset of the disease. Hazard ratios of J01C (Beta-
Lactam antibacterials, Penicillins), J01DB (First-generation Cephalosporins), J01DD 
(Third-generation Cephalosporins), J01F (Monobactams), and J01G (Aminoglycoside 
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antibacterials) are significantly greater than 1 for asthma and atopic dermatitis. Among 
them, hazard ratios of J01C were 1.682 and 1.408 in asthma and atopic dermatitis, 
respectively, and it has the highest hazard ratios among antibiotics. The hazard ratio 
estimates for other risk factors are almost identical to estimates of antibiotic use.
However, in the cox proportional hazard model estimated by antibiotic type, the hazard 
ratio for respiratory disease was somewhat smaller than that estimated from antibiotic 
use.
Asthma Atopic dermatitis
HR 95%CI P-value HR 95%CI P-value
J01C - Beta-Lactam antibacterials, Penicillins
Yes 1.682 1.668 1.695 <.0001 1.408 1.399 1.417 <.0001
No (Reference)
J01DB - First-generation Cephalosporins
Yes 1.129 1.117 1.141 <.0001 1.103 1.093 1.114 <.0001
No (Reference)
J01DD - Third-generation Cephalosporins 
Yes 1.435 1.428 1.443 <.0001 1.312 1.306 1.318 <.0001
No (Reference)
J01F - Monobactams
Yes 1.477 1.470 1.485 <.0001 1.295 1.289 1.301 <.0001
No (Reference)
J01G - Aminoglycoside antibacterials
Yes 1.176 1.165 1.188 <.0001 1.128 1.118 1.138 <.0001
No (Reference)
Sex
Male 1.110 1.105 1.115 <.0001 1.089 1.085 1.094 <.0001
Female  (Reference)
Respiratory disease before each disease




Seoul 0.980 0.967 0.993 0.0022 1.032 1.021 1.044 <.0001
Metropolitans 1.037 1.024 1.050 <.0001 1.055 1.043 1.066 <.0001




1st 0.989 0.982 0.996 0.0016 0.883 0.878 0.888 <.0001
2nd 0.978 0.971 0.984 <.0001 0.906 0.901 0.911 <.0001
3rd 0.995 0.988 1.002 0.1541 0.957 0.951 0.962 <.0001
4th (Reference)
Paracetamol before each disease
Yes 0.501 0.499 0.504 <.0001 0.638 0.635 0.642 <.0001
No (reference)
Table 8 Cox proportional hazard model of the risk factors of asthma and atopic dermatitis 
by type of antibiotics
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Ⅴ. Conclusion
In this thesis, I investigated the effects of antibiotics on the incidence of asthma and 
atopic dermatitis. Asthma and atopic dermatitis are similar to those caused by the 
allergic march, so it is necessary to study both diseases together rather than studying 
only one disease. Because the risk factors are complex in both diseases, it is difficult to 
estimate the exact effect of the risk factors. Among them, the use of antibiotics has been 
known to be a major risk factor for asthma and atopic dermatitis because it causes 
obstacles to intestinal microbiomes in the newborn infant or changes the composition of 
intestinal microbiomes in the long term. Therefore, this study examined the effect of 
antibiotics use in Korea on the incidence of asthma and atopic dermatitis in 2011-2013, 
and further examined the effect of type by antibiotics on the incidence of asthma and 
atopic dermatitis. To do this, this study made efforts to divide dependent variables, 
independent variables, covariates, confounders into the model by clarifying DAG using 
previous research. The Kaplan-Meier analysis, log-rank test and Cox proportional 
hazard model were used to estimate the effect.
The major difference from previous studies is the fact that the subjects are set as 
infants Prevalence and incidence of asthma and atopic dermatitis less than 1-year-old 
were presented and the effect of antibiotic use was estimated. Most of the previous 
studies on pediatric asthma have been conducted on subjects aged 5-18 years. Children 
aged 5 years or older were able to use the questionnaire method as in the ISAAC study, 
so pediatric asthma was mainly studied at 5-18 years of age. On the other hand, subjects 
who are less than 5 years cannot use the questionnaire method and pediatric asthma
under 5years of age can be difficult to estimate because it appears in the form of 
temporary wheezing in children under 5 years of age. However, this study was able to 
study pediatric asthma in subjects less than 5 years of age because it gave operational 
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definition more than adequate period in order to reduce the bias that regards temporary 
wheezing as pediatric asthma.
In this study I also examined the effect of different types of antibiotics on the 
incidence of asthma and atopic dermatitis, as well as the presence or absence of 
comprehensive antibiotics. There are very few studies to classify antibiotics by type and 
to determine the relationship with asthma and atopic dermatitis. A representative study 
on the occurrence of asthma according to the use of antibiotics was conducted (Ortqvist,
2014). The study based on Swedish children, used about 500,000 people in 2006. 
The results of this study showed that the use of antibiotics and their types have an 
influence on the incidence of asthma and atopic dermatitis. Similar to previous studies, 
the risk of asthma and atopic dermatitis is higher in males in the pediatric population, 
and in the respiratory disease, similar results were obtained as in previous studies. The 
prevalence and incidence rate of asthma and atopic dermatitis were higher in antibiotics 
group. In the analysis, this study used an analysis to correct major confounder of 
respiratory diseases or to control the other risk factors in DAG. Survival curves were 
estimated using the Kaplan-Meier curve. The first Kaplan-Meier curve was divided into 
three groups: pre-asthma antibiotics, antibiotic-free, and all subjects. Both asthma and 
antibiotics showed a rapid decrease in survival function in patients with antibiotics 
before disease. In the second Kaplan-Meier curve, the survival function of the four 
groups was estimated by dividing into the use of antibiotics as well as respiratory 
diseases. The results showed that the group with antibiotic and respiratory disease had a 
high risk of developing asthma and atopic dermatitis. However, the results of antibiotic-
free and respiratory disease-free groups were slightly different from those anticipated.
In the Cox proportional hazard model, only the effects of antibiotics on asthma and 
atopic dermatitis were estimated by controlling the effects of the risk factors identified 
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in the DAG. The hazard ratios of antibiotic use in both asthma and atopic dermatitis ere
estimated. Hazard ratios were also estimated for antibiotic use by type. Among them, the 
hazard ratio for the use of J01C, beta-lactam antibacterials and penicillins was estimated 
to be the highest. It should be noted that the p-value can be significant even though it is 
not actually significant because the number of subjects used in the model is large. In this 
case, the effect of asthma and atopic dermatitis on the occurrence of asthma and atopic 
dermatitis should be interpreted by considering the estimated effect size (hazard ratio) as 
well as hypothesis testing by p-value.
The claims data used in this study does not include prescriptions for drugs that can be 
purchased without prescription, such as non-paying medical care or over the counter 
(OTC). In addition, there may be an error because it is difficult to exclude the diagnosis, 
the individual difference in the procedure, and the customary factors. There is a study 
that there is an error in the accuracy of the claims data about 70% of the degree of 
agreement between the medical records. The family history information, which is an 
important covariate of the risk factors of the disease, is missing and the possibility of 
bias cannot be excluded in the estimation. As a limitation of the analysis, Survival 
analysis was carried out from the time of birth to the time of illness. The data of the 
received claim is not composed of data on the date of birth, but consists of quarterly data. 
Since the date of birth is set to a representative value with a median date of the quarter, 
there may be an error in the estimation of the survival function.
In this study I confirmed the association between the use of antibiotics and the 
incidence of asthma and atopic dermatitis. However, it is very difficult to consider all 
risk factors for asthma and atopic dermatitis with complex risk factors and results 
depend on the characteristics of the data. Nevertheless, the almost entire Korean subject 
born between 2011 and 2013 were used for the analyses and the frequency analysis of 
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this study and the estimation of the effect of antibiotic use may provide informative 
results even though results depend on the operational definition of appropriate asthma 
and atopic dermatitis. The results of this study suggest that the use of antibiotics in 
infancy be causal factors for asthma and atopic dermatitis incidence. Further studies are 
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국문 초록
영아기 항생제 사용이 천식 및 아토피
피부염 발생에 미치는 영향




연구 배경: 천식과 아토피 피부염은 신생아 시기에 알레르기 행진(allergic 
march)에 의해 두 질환이 함께 발병하거나 어느정도의 선후 관계를 가지며 함께
발생한다고 알려져 있다. 이러한 관계 때문에 두 질환에 대해 분석을 같이
실시하여 두 질환의 행태와 위험요인을 연구해야 한다. 천식과 아토피 피부염은
다양하고 복합적인 위험요인을 가진다고 알려져 있다. 인구학적 요인, 감염성
질병 관련 요인, 약제 사용에 따른 요인, 식이 관련요인, 대기 환경 요인 등의 여러
요인들이 혼재되어 복합적으로 작용한다고 알려져 있다. 여러 위험 요인 중
항생제의 복용은 방선균의 감소, 박테리아의 증가, 효소의 감소 등과 같은 장내
미생물에 대한 장기적인 변화를 야기한다고 알려져 있다. 또한 성숙하지 않은
미소 생물상 증가를 야기하기 때문에 유아기 면역 체계의 적절한 성장을 방해하고
면역 내성의 발달을 저해함으로써 천식이나 아토피 피부염과 같은 알러지에 대한
과민성 발생을 증가시킨다고 알려져 있다. 그럼에도 불구하고, 5 세 미만의 천식
및 아토피 피부염의 진단 방법의 어려움으로 인해 질병 현황 및 항생제를 포함한
위험 요인에 대한 연구가 활발히 이루어 지지 않았다.
연구 목적: 우리나라의 2011 년도부터 2013 년도의 출생아를 대상으로 천식 및
아토피 피부염 발생 현황을 파악하고 영아기 항생제의 복용에 따른 천식과 아토피
피부염의 발생 위험에 미치는 영향을 탐색하고자 한다. 또한, 항생제 종류 별
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복용에 따른 천식과 아토피 피부염의 발생 위험에 미치는 영향도 분석하고자 한다.
연구 방법: 본 연구는 한국의 1 세 미만 영아의 항생제 복용에 따른 천식 및
아토피 피부염 발생의 위험을 파악하여 두 요인의 연관성을 밝히고자 2011 년도와
2012 년도, 2013 년도에 출생한 신생아의 건강보험심사평가원 청구데이터를
활용하였다. 건강 보험 심사 평가원 청구 자료의 분석 과제 번호는
M2016082442 로 원격 접속 시스템 신청 과정을 거쳐 자료 접속 권한을 부여
받았다. 명세서, 진료내역, 처방전 관련 자료를 환자 식별 번호와 key 번호를
기준으로 통합하여 본 연구에 활용 될 자료를 구성하였다. 문헌 조사를 통해
방향성 비 순환 그래프를 제시하였고, 이를 활용하여 이후 분석에서 교란 요인의
설정 및 설명 변수의 선택을 실시 하였다. 자료의 특성을 알아보기 위해
빈도분석을 실시하였고, 천식과 아토피 피부염의 현황을 알아보기 위해 유병률과
발생률을 추정하였다. 발생률의 추정은 인-월을 기준으로 추정하였다. 카플란-
마이어의 생존 곡선을 통해 질환 발생 이전 항생제 사용 군, 질환 발생 이전 항생제
사용과 호흡기 질환 유무로 나눈 군, 신우신념 발생과 항생제 사용 대상자에서의
호흡기 질환 유무로 나눈 군에 대해 위험 함수를 추정하였다. 마지막으로, 
항생제의 사용이 천식 및 아토피 피부염 발생에 대한 위험비를 추정하기 위하여
콕스 비례 위험 모형을 활용하였다. 교란변수및 설명변수는 위에서 언급한
DAG 를 통하여 정할 수 있었다. 또한 WHO 에서 제시한 항생제 종류로 종류 별
천식 및 아토피 피부염 발생에 대한 위험비를 추정 하였다.
연구 결과: 천식의 경우 2011-2013 년의 생후 1 년 미만의 대상자에게서 약
60%의 유병률과 0.0238 의 발생률(인-월)이 확인되었고, 아토피 피부염의 경우는
약 80%의 유병률과 0.0845 의 발생률(인-월)이 확인되었다. 두 질병 모두 질환 발생
이전에 항생제를 사용한 군에서 유병률과 발생률이 높음을 확인 할 수 있었다. 
DAG 에서 항생제의 복용과 천식 및 아토피 피부염의 주된 교란요인이 호흡기
질환이므로 항생제의 복용과 호흡기 질환 유무를 기준으로 군을 나누어 카플란
마이어 생존 곡선을 추정하였다. 천식과 아토피 피부염 모두 항생제 사용과
호흡기 질환 군에서 질환 발생 위험이 가장 높았다. 로그-순위 검정 또한
유의확률이 0.0001 보다 작으므로 군간 생존 함수의 차이가 있다고 볼 수 있었다. 
마지막으로, 콕스 비례 위험 모형에서 천식 발생 이전 항생제 사용은 천식 발생에
대해 위험비가 1.556 (신뢰구간 : 1.543 – 1.569)로 추정되었고, 아토피 피부염 발생
이전 항생제 사용은 아토피 피부염 발생에 대해 위험비가 1.369 (신뢰구간 : 1.360 
– 1.378)로 추정 되었다. 호흡기 질환의 천식 발생에 대한 위험비는 1.518 
(신뢰구간 : 1.510 – 1.527), 아토피 피부염 발생에 대한 위험비는 1.210 
(신뢰구간 :1.205 – 1.215)로 추정되었다. 항생제 종류별 사용에 대해서 콕스 비례
위험 모형에 적합 시킨 결과 중, J01C 에 해당하는 베타락탐-페니실린 계가 천식과
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아토피 피부염 모두의 위험비에서 각각 1.682 (신뢰구간 : 1.668 – 1.695), 1.408
(신뢰구간 : 1.399 – 1.417)으로 가장 높은 것을 확인 할 수 있었다.
결론: 본 연구에서는 천식과 아토피 피부염의 발생 이전의 항생제의 사용이
천식과 아토피 피부염의 발생에 영향을 미치는 요인임을 확인 할 수 있었다. 특히
항생제의 종류 중 베타-락탐, 페니실린계의 질환 발생 위험 영향이 가장 큰 것을
확인 할 수 있었다. 따라서 신생아의 항생제 사용에 있어서 천식 및 아토피
피부염의 발생 위험을 고려한 처방 및 사용이 필요하다.
주요어: 천식, 아토피 피부염, 항생제, 콕스 비례 위험 회귀 모형, 
카플란 마이어 생존 곡선
학번 : 2015-24013
